A soluble fragment of the EGFR extracellular ligand domain can be detected by ELISA in the blood of cancer patients, including NSCLC patients, and may also be elevated at an early stage of carcinogenesis in asbestosis patients [33]. This evidence concerns the gene EGFR and asbestosis.